Trial intelligence / Profile preview

T900607 in previously treated gastric carcinoma

NCT00054249Phase 2Completed

Sponsor
University Hospitals Seidman Cancer Center
Start
Sep 2002
Primary completion
Oct 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of t900607 in gastric cancer (GC), gastroesophageal junction cancer, sponsored by University Hospitals Seidman Cancer Center. Started Sep 2002; status: completed.

02

Drugs

t900607
03

Conditions

gastric cancer (GC)gastroesophageal junction cancer

Beyond the preview

Go deeper on NCT00054249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00054249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call